[Prevalence of metabolic syndrome in elderly patients].
OBJECTIVE
To determine the prevalence of metabolic syndrome (MS) according to the definitions of the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) and the International Diabetes Federation (IDF) and its relation to cardiovascular disease (CVD) in hospitalized elderly patients.


METHODS
This descriptive and prospective study (February-March 2011) included 200 consecutive patients hospitalized in a Geriatric Department. Sociodemographic, clinical and biochemical data was collected.


RESULTS
The prevalence of MS was 65% (NCEP-ATP III) and 67.5% (IDF) and was greater in women (NCEP-ATP III=72.8%, IDF=73.6%) than in men (NCEP-ATP III=50.7%; IDF=56.3%). The mean age of patients diagnosed with MS by both diagnostic criteria were similar: 84.7 years. MS was not associated with an increased prevalence of CVD.


CONCLUSIONS
MS is highly prevalent in elderly hospitalized patients, being higher in women, with both diagnostic criteria (NCEP- ATP III and IDF). In our population the MS was not associated with an increased prevalence of CVD.
Servicio de Geriatría, Hospital Nuestra Señora de Gracia, Zaragoza, España. Electronic address: mecastro@salud.aragon.es.
María Elena
ME
Castro Vilela
Servicio de Geriatría, Hospital Nuestra Señora de Gracia, Zaragoza, España.
Raquel María
RM
Quílez Pina
Servicio de Geriatría, Hospital Nuestra Señora de Gracia, Zaragoza, España.
José Luis
JL
Bonafonte Marteles
Servicio de Geriatría, Hospital Nuestra Señora de Gracia, Zaragoza, España.
Teresa
T
Morlanes Navarro
Servicio de Endocrinología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
Fernando
F
Calvo Gracia
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology*; D015995:Prevalence; D011446:Prospective Studies
Ancianos; Cardiovascular disease; Elderly; Enfermedad cardiovascular; Metabolic syndrome; Síndrome metabólico